Plasma biomarkers to detect prevalent, or predict progressive, HIV-1-associated tuberculosis

[1]  Daniel E. Zak,et al.  Four‐Gene Pan‐African Blood Signature Predicts Progression to Tuberculosis , 2018, American journal of respiratory and critical care medicine.

[2]  G. Sireci,et al.  Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease , 2018, PloS one.

[3]  Elisa M. Tjon Kon Fat,et al.  Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis , 2018, Scientific Reports.

[4]  S. Lawn,et al.  ART and prevention of HIV-associated tuberculosis. , 2015, The lancet. HIV.

[5]  A. Pozniak,et al.  Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland. , 2015, The lancet. HIV.

[6]  G. Maartens,et al.  Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial , 2014, The Lancet.

[7]  S. Kaufmann,et al.  Central Memory CD4+ T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis , 2014, The Journal of infectious diseases.

[8]  P. Andersen,et al.  Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1− IL-2–Secreting Central Memory Cells , 2013, The Journal of Immunology.

[9]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[10]  G. Maartens,et al.  Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis. , 2009, American journal of respiratory and critical care medicine.

[11]  H. Pollack,et al.  Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  G. Maartens,et al.  Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[14]  A. Dunning,et al.  CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  M. Pai,et al.  Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[16]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[17]  P. Klenerman,et al.  Dynamic Relationship between IFN- and IL-2 Profile of Mycobacterium tuberculosis-Specific T Cells and Antigen Load , 2007 .

[18]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[19]  Gerhard Walzl,et al.  Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report , 2009, BMC pulmonary medicine.